| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5fc35782f9b1bd8e4a688773dfcfdf14 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K6-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- |
| filingDate |
2011-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8355b61a68211dfadcc702a42cf1d67b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db1da5d2eb8e4df543709060b8688ff1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f97ba46053ecceab39c38aff5fccd5f |
| publicationDate |
2011-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2011162560-A |
| titleOfInvention |
Oral insulin treatment and protocol |
| abstract |
The present invention provides a method for treating reduced glucose tolerance and early and late diabetes in mammals, preventing the development of overt diabetes in type 2 diabetes, and treating the current level of glycemic control dysfunction. The method includes orally administering insulin and a delivery substance that facilitates absorption of insulin from the gastrointestinal tract over a long period of time at or just before mealtime. In addition to administering a fast-acting insulin that provides an initial insulin peak, it also includes administering a slow-acting insulin that results in a second insulin peak that occurs later but has a long duration. These methods achieve improved glycemic control without the risk of hypoglycemia, hyperinsulinemia and weight gain, and without the frequent glycemic monitoring normally associated with insulin therapy. [Selection] Figure 1 |
| priorityDate |
2003-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |